scholarly article | Q13442814 |
P356 | DOI | 10.1053/J.GASTRO.2007.01.034 |
P8608 | Fatcat ID | release_fviyxvji2fdprnglf4uwvdv3re |
P698 | PubMed publication ID | 17408664 |
P2093 | author name string | Je-Ho Lee | |
In Young Park | |||
Bo Hwa Sohn | |||
Young-Hwa Chung | |||
Dong Jin Suh | |||
Eunsil Yu | |||
Young Ik Lee | |||
Stefan J Surzycki | |||
P2860 | cites work | DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Hepatitis B virus | Q6844 |
hepatitis B | Q6853 | ||
P304 | page(s) | 1476-1494 | |
P577 | publication date | 2007-01-25 | |
P1433 | published in | Gastroenterology | Q4039279 |
P1476 | title | Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein | |
P478 | volume | 132 |
Q42981671 | A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. |
Q38239671 | Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review). |
Q34464701 | Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas |
Q39045130 | An overview of epigenetics in Chinese medicine researches |
Q45366085 | Analysis of DNA methylation in human BK virus |
Q36216577 | Array-based profiling of the differential methylation status of CpG islands in hepatocellular carcinoma cell lines |
Q59358229 | Cancer Progression Goes Viral: The Role of Oncoviruses in Aggressiveness of Malignancies |
Q33988586 | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development |
Q64110985 | Control of viral infections by epigenetic-targeted therapy |
Q37371733 | Current progress in epigenetic research for hepatocarcinomagenesis |
Q41970979 | DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes |
Q50042001 | DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis |
Q39711686 | DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcr |
Q111349214 | DNA hypermethylation level of ACTL6A may promote BmNPV infection in B. mori |
Q33617129 | DNA methylation: potential biomarker in Hepatocellular Carcinoma. |
Q36039537 | DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis |
Q33579896 | DNA methyltransferases: a novel target for prevention and therapy |
Q36993940 | Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis |
Q41688315 | Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma. |
Q88669421 | Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells |
Q39688414 | Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. |
Q40090479 | Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma |
Q26827297 | Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer |
Q37225429 | EVI1 promotes cell proliferation in HBx-induced hepatocarcinogenesis as a critical transcription factor regulating lncRNAs |
Q60302168 | Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma |
Q38667127 | Epigenetic Dysregulation in Virus-Associated Neoplasms |
Q38692795 | Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises |
Q36244215 | Epigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma |
Q38286091 | Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma |
Q35665775 | Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection |
Q36415128 | Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis. |
Q36001887 | Epigenetic mechanisms in virus-induced tumorigenesis |
Q90416073 | Epigenetic modulation in chronic hepatitis B virus infection |
Q35666404 | Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma. |
Q38446849 | Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer |
Q35243806 | Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. |
Q37781197 | Epigenetic reprogramming of host genes in viral and microbial pathogenesis |
Q34619389 | Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis. |
Q30157007 | Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma |
Q35793851 | Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. |
Q42234880 | Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway |
Q26849263 | Epigenetics in liver disease |
Q28079271 | Epigenetics in liver disease: from biology to therapeutics |
Q39563462 | Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer |
Q45378283 | Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation |
Q28383729 | From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms |
Q38415638 | Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma |
Q35084738 | Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. |
Q38974653 | Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis |
Q39372582 | Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. |
Q40722555 | Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers |
Q58612842 | Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy |
Q36689117 | Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes. |
Q90707727 | Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma |
Q36401985 | Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study |
Q36002022 | Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure. |
Q34552627 | Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells |
Q41130200 | HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells |
Q46669089 | HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma |
Q36724900 | HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. |
Q90284131 | Hepatitis B Virus X Protein Stimulates Virus Replication Via DNA Methylation of the C-1619 in Covalently Closed Circular DNA |
Q38690987 | Hepatitis B Virus X and Regulation of Viral Gene Expression |
Q26775635 | Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte |
Q39119845 | Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. |
Q45353493 | Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin |
Q37621008 | Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis |
Q39034561 | Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma |
Q39682076 | Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis |
Q40068189 | Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA. |
Q45387956 | Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells |
Q38110262 | Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis |
Q37680071 | Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma |
Q35606904 | Hepatitis B virus infection and the risk of hepatocellular carcinoma |
Q39181943 | Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator |
Q45324907 | Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3. |
Q33530611 | Hepatitis B virus replication induces methylation of both host and viral DNA. |
Q27024874 | Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma |
Q45389152 | Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription |
Q38543225 | Hepatitis viruses exploitation of host DNA methyltransferases functions |
Q37571496 | Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma. |
Q38156891 | How virus persistence can initiate the tumorigenesis process |
Q54499445 | Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas. |
Q37961724 | Hypomethylation of repeated DNA sequences in cancer. |
Q45372624 | IL-32: A Host Proinflammatory Factor against Influenza Viral Replication Is Upregulated by Aberrant Epigenetic Modifications during Influenza A Virus Infection |
Q92316251 | Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel? |
Q28730441 | Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma |
Q34732677 | Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter |
Q34401887 | Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines |
Q64290412 | Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma |
Q38837061 | Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential |
Q38261140 | Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine |
Q28743228 | Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma |
Q34284404 | MicroRNAs associated with HBV infection and HBV-related HCC. |
Q93140597 | MicroRNA‑20 induces methylation of hepatitis B virus covalently closed circular DNA in human hepatoma cells |
Q33855801 | Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma |
Q26823512 | Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis |
Q27686923 | Molecular mechanisms underlying occult hepatitis B virus infection |
Q26745338 | Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances |
Q98185008 | Multiple roles for hepatitis B and C viruses and the host in the development of hepatocellular carcinoma |
Q37418293 | Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. |
Q37174094 | Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma |
Q38018996 | Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation |
Q40281137 | Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions. |
Q35989817 | RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients |
Q39437275 | Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes. |
Q35995683 | Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. |
Q33968083 | Serum secreted frizzled-related protein 5 levels differentially decrease in patients with hepatitis B virus-associated chronic infection and hepatocellular carcinoma |
Q26773251 | Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma |
Q84032542 | Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression |
Q49956187 | Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma |
Q39924163 | Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression |
Q26771469 | The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection |
Q37142007 | The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer |
Q64214332 | The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases |
Q39890460 | The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines |
Q35081469 | The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease |
Q34561172 | The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma |
Q37151661 | Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation |
Q28389231 | Tumor suppressor and hepatocellular carcinoma |
Q37681282 | Viral epigenomes in human tumorigenesis. |
Q34617749 | Viral hepatocarcinogenesis |
Q34135741 | Viral hit and run-oncogenesis: Genetic and epigenetic scenarios |
Q38643087 | Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms |
Q88595072 | [Chloroquine induces apoptosis of human hepatocellular carcinoma cells in vitro by miR-26b-mediated regulation of Mcl-1] |
Q38986675 | miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway |
Q36230642 | microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma. |
Search more.